subscribe
 

Pioneering zebrafish research provides breakthrough in the development of new treatments for epilepsy

The prospect of developing new treatments for epilepsy sufferers has been given a boost by a pioneering discovery at a leading international...

Targeted skin cancer drug launches in UK

Vemurafenib, marketed by Roche as Zelboraf, is the first personalised treatment that has been shown in clinical trials to increase survival time for patients with a specific BRAF gene mutation. The European Commission has licensed the drug...

Natural products drug discovery symposium announced

Groundbreaking research into the development of new medicines from the earth’s natural resources will be the focus of a symposium in March, hosted by the University of Aberdeen.

Promising new compound for treating stroke

Researchers at the University of Copenhagen have designed, produced and patented a new chemical compound for the possible treatment of brain damage caused by stroke.

Rainforest plant combats multi-resistant bacterial strains

Aggressive infections in hospitals are an increasing health problem worldwide. The development of bacterial resistance is alarming. Now a young Danish scientist has found a natural substance in a Chilean rainforest plant that effectively...

Combined oral contraceptive pill helps painful periods

A large Scandinavian study, that has been running for 30 years, has finally provided convincing evidence that the combined oral contraceptive pill does, indeed, alleviate the symptoms of painful menstrual periods reports scientists from the...

Heptares scientist report the first use of structure-based drug design to discover GPCR-targeted drug candidate

Heptares Therapeutics, the leading GPCR drug discovery company, provides an update on recent scientific publications that highlight its unique ability to generate valuable information on GPCR structures and ligand binding.

Protein researcher receives prestigious European award

Professor Matthias Mann has just received the prestigious Louis-Jeantet Prize for medicine for his outstanding results in areas such as cancer research. His work has significant therapeutic implications that could improve the diagnosis and...

Drug screening assays in living zebrafish disease models

Microplate reader systems enable development of in vitro and in silico assays that allow high throughput screening

New monoclonal antibody drugs

ModiQuest Research offer an intelligent approach to antibody generation, cloning, modification and cell line production. Its offering...

Use of hyaluronic acid to extend drug release in osteoarthritis applications

Novozymes Biopharma to present latest advances in drug delivery technology at Controlled Release Society Meeting

Hitting moving RNA drug targets

RNA now is understood to perform a number of other vital roles in the cell

Inflammatory bowel disease

Lipid Therapeutics announces positive topline Phase IIb results with LT-02 in patients with ulcerative colitis

Production of proteins with extended circulatory half-life

Albumin fusion technology designed to overcome challenges associated with the therapeutic use of peptides and proteins

Productive SPE sample preparation

MaxiLute is a 48-well SPE microplate system laboratories currently using SPE cartridges

Hyaluronic acid for ophthalmology applications

New recombinant hyaluronic acid for eye care and ophthalmic drug delivery

Free models to predict toxicity of compounds

StarDrop’s glowing molecule provides visual link between chemical structure and predicted toxicities

Disease-specific human embryonic stem cell lines

University of Michigan joins a small handful of US universities that are creating disease-specific human embryonic stem cell lines

Improving respiratory parameters in obstructive sleep apnea patients

Exploratory clinical study carried out with AMPAKINE compound, CX1739 in subjects with sleep apnea

Focus on enhanced assays to detect cancer cells

Demand continues to grow for new and improved assays to detect cancer cells. The latest technologies, as Sean Ottewell reports, focus on...

Pages

Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe